Looking Into SCYNEXIS’s Return On Capital Employed
According to data from Benzinga Pro, during Q4, SCYNEXIS‘s (NASDAQ:SCYX) reported sales totaled $1.40 million. Despite a 51.23%…
Dow Rises 100 Points; Accelerate Diagnostics Shares Spike Higher
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining around 100 points on Thursday.
The Dow traded up 0.31% to 32,819.16 while the NASDAQ rose 0.63% to 12,001.83. The S&P 500, also rose, gaining, 0.46% to 4,046.40.
12 Health Care Stocks Moving In Thursday’s Intraday Session
Gainers SCYNEXIS (NASDAQ:SCYX) shares moved upwards by 66.8% to $2.79 during Thursday’s regular session. As of 13:30 EST,…
Why Bed Bath & Beyond Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday’s Mid-Day Session
Gainers
SCYNEXIS, Inc. (NASDAQ: SCYX) shares climbed 68% to $2.8184 after the company announced an exclusive license agreement with GSK for Brexafemme, in which the company will receive an upfront payment of $90 million.
GSK Bets On Scynexis’ FDA-Approved Antifungal Drug For Over $500M In Bio Bucks
GSK plc (NYSE:GSK) and Scynexis Inc (NASDAQ:SCYX) have entered into an exclusive license agreement for Brexafemme (ibrexafungerp tablets). The FDA approved the antifungal…
12 Health Care Stocks Moving In Thursday’s Pre-Market Session
Gainers SCYNEXIS (NASDAQ:SCYX) shares rose 91.0% to $3.19 during Thursday’s pre-market session. The company’s market cap stands at…
12 Health Care Stocks Moving In Monday’s Intraday Session
Gainers Alimera Sciences (NASDAQ:ALIM) shares moved upwards by 33.2% to $1.8 during Monday’s regular session. As of 13:30…
Guggenheim Initiates Coverage On SCYNEXIS with Buy Rating, Announces Price Target of $8
Guggenheim analyst Vamil Divan initiates coverage on SCYNEXIS (NASDAQ:SCYX) with a Buy rating and announces Price Target of $8.
